<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Plasma metabolite panel (29 metabolites) distinguishes Colorectal Cancer (Stage 0/I/II) — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Plasma metabolite panel (29 metabolites)</strong>
  <span class="pred">&mdash;distinguishes&rarr;</span>
  <strong>Colorectal Cancer (Stage 0/I/II)</strong>
</div>
<div class="entity-id">UNKNOWN:plasma metabolite panel (29 metabolites) &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: DB Referenced (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 20.32<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; DB Ref 0.5 &middot; Text Derived 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts &minus;0.5). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.50 (DB Referenced, 1 paper)<br>Score from 17 citations: <strong>20.32</strong><br><span style="color:#888">9&times; extends (+10.72) &middot; 7&times; supports (+9.29) &middot; 1&times; applies (+0.30)</span><br>Neighbourhood: 22.90</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="DB Referenced"></span><span>DB Referenced</span><a href="https://doi.org/10.18632/oncotarget.15081">10.18632/oncotarget.15081</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 17 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:78px"></span><span>7</span><span class="cite-subtotal">&middot; +9.29</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">Fatty acids — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+6.00</span><a href="../claim/6ad1651b9e44eeed.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolic profile — is_biomarker_for → metachronous metastasis in stage II colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/649eeb54aa596ed5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">DNA methylation — is_biomarker_for → Colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/d1fe89a5c42232d1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">microRNA — is_biomarker_for → Colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/f25cb0e88b0f6688.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lysophosphatidylcholine (LysoPC) — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.79</span><a href="../claim/da12e4ff94bff4d9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylglycerol — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/5ccf3ca6907853fc.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Sterol esters — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/2ddf49d0d1512692.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:100px"></span><span>9</span><span class="cite-subtotal">&middot; +10.72</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">ceramides — is_biomarker_for → colorectal adenocarcinoma tissue</span><span class="cite-claim-weight">+5.57</span><a href="../claim/fbddabef2bccbbf8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphatidylcholine (PC 16:0/18:1) — distinguishes → pMMR vs dMMR colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/7cd9963dbde9d220.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolic profile — distinguishes → metachronous metastasis in stage II colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/8c2c7999e9a14ad4.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolic profile — predicts → metachronous metastasis in stage II colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/5eb150f836c0cfab.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">fecal hemoglobin — distinguishes → Colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/b7e485cb03d43c01.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PC(18:0/18:1) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/8477d23a810774c9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PE(18:0/20:4) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/bb50e0c283aa54f1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylethanolamine — increases → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.60</span><a href="../claim/367abe64d5d037b2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lipogenic phenotype (upregulated lipogenesis) — correlates_with → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.60</span><a href="../claim/fc1a0b488fe38bb6.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:11px"></span><span>1</span><span class="cite-subtotal">&middot; +0.30</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine — increases → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.30</span><a href="../claim/bb313c103d3f8b81.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>95c047c5809cf90e</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:plasma metabolite panel (29 metabolites)">UNKNOWN:plasma metabolite panel (29 metabolites)</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
